Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$CAPR Still holding this too.
$HTBX holding in three accounts.
Good late afternoon AF!
$Good afternoon AF!
HOTT and HUMID in Va Bch today. Whew!
Congrats and nice call
$SNSS i still have .28s from catching your post on 7/17
$SNSS amazing how its running tonight.
$CAPR 8.10
$ADMP nice trading range today too. This upward momentum will be welcome next week.
$CAPR lol, I was just about to hit you up too. If that DMD news drops, OMG, hold on.
$SRPT has a yearly trading range from 72-175. That's HUGE!
$CAPR $COCP $FET $HTBX $BNTX $IBIO $PFE for some of my holds and have a couple more in another account.
$CAPR the way its trading, easily
$CAPR new hod 7.73
$CAPR on the move again
$FET tiny more info. The minimum participation condition to the closing of the exchange offer is 95% of the approximately $328 million principal amount of the existing notes. However, as of the preliminary tender deadline, tenders from only 86.4% of the existing notes had been received. The minimum participation condition must be satisfied or waived prior to consummation of the exchange offer.
$FET to add. The minimum participation condition to the closing of the exchange offer is 95% of the approximately $328 million principal amount of the existing notes. However, as of the preliminary tender deadline, tenders from only 86.4% of the existing notes had been received. The minimum participation condition must be satisfied or waived prior to consummation of the exchange offer.
$FET could move higher next week.
The Company also announced that it is extending the Early Tender Time and Consent Time (each as defined in the Company’s registration statement (the “Registration Statement”) on Form S-4, including a preliminary prospectus, which is subject to change, filed July 6, 2020 by the Company with the Securities and Exchange Commission, which registration statement is not yet effective) of its Exchange Offer and Consent Solicitation. Accordingly, the Early Tender Time and Consent Time will occur at the same time the Exchange Offer is scheduled to expire immediately after 11:59 P.M., New York City time, on July 31, 2020, unless extended or earlier terminated by the Company in its sole discretion
$FET This could move more next week too.
The Company also announced that it is extending the Early Tender Time and Consent Time (each as defined in the Company’s registration statement (the “Registration Statement”) on Form S-4, including a preliminary prospectus, which is subject to change, filed July 6, 2020 by the Company with the Securities and Exchange Commission, which registration statement is not yet effective) of its Exchange Offer and Consent Solicitation. Accordingly, the Early Tender Time and Consent Time will occur at the same time the Exchange Offer is scheduled to expire immediately after 11:59 P.M., New York City time, on July 31, 2020, unless extended or earlier terminated by the Company in its sole discretion
$ADMP making another move today
Nice move!
$FET .5190 HOD.
$CAPR 7.67 HOD
$CAPR 7.67 HOD
$CAPR 7.40
$CAPR 7.37
$CAPR will do next time. It does look real promising:)
$CAPR waking up today
Couldn't pass that opportunity up this morning. Now lets rip :)
$Good Morning AF!
$HTBX added $2.40
$IBIO added $5.15
$IBIO the monster has awakened
Welcome back! Missed ya posting your awesome trades. Have a good end to the trading week.
$Good Morning AF!
$BNTX phase 3 trials start any day now and it requires two shots then a booster. If this continues with positive results and that is the final dosing then this is HUGE money.
$PFE
PFIZER ADVANCES BATTLE AGAINST COVID-19 ON MULTIPLE FRONTS
Thursday, April 09, 2020 - 07:50am
1. Anti-viral compounds show activity against SARS-CoV-2 in preclinical screening
2. Pfizer and BioNTech enter into collaboration agreement to co-develop potential COVID-19 vaccine
3. Company shares additional data and analysis of azithromycin
4. Launch of two new studies to provide insights on the interaction between S. pneumoniae and SARS-CoV-2
5. Pfizer explores studies of JAK inhibitor tofacitinib in patients with COVID-19-related pneumonia
$PFE phase 3 human trials start any day now. The dosing is 2 shots then a booster.
$HTGM .77 AH
$IBIO I should have backed the truck up too. Lol
$PFE Phase 3 trials start within days. Two shots then a booster.
$IBIO $6.20
$IBIO back to $6
$ABIO I'm out for now to see if it drops more. Watching now